Levels of CLEC9A, a highly specific marker for mature cDC1, have correlated with improved survival in different cancer types40, and previous reports have shown that high densities of intratumoral LAMP+ DCs are associated with tertiary lymphoid structures, Th1 polarization, and cytotoxic activity41,42. Here, CLEC9A is linked to cancer.